Io Therapeutics, Inc., announces presentation of data on its RAR gamma agonist compound IRX5010 demo
资讯
2024-11-11
Io Therapeutics, Inc., announces presentation of data on its RAR gamma agonist compound IRX5010 demonstrating inhibition of tumor infiltrating myeloid derived suppressor cells, promotion of tumor infi...